Carcinoma of unknown primary in a single site

Carcinoma of an Unknown Primary Site

Volumn , Issue , 2006, Pages 133-146

  Lesimple, Thierry ^a   Balaña, Carmen ^b  

^a CENTRE EUGÈNE MARQUIS   (France)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82555171350     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (44)

1. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994; 12:1272-1280.
2. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39: 1990-2005.
3. Belleannée G. Tumeurs sans primitif connu: place de l'immunohistochimie. Oncologie 2004; 6:252-255.
4. Rades D, Kuhnel G, Wildfang I, Borner AR, Schmoll HJ, Knapp W. Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann Oncol 2001; 12:1605-1609.
5. Hübner G, Wildfang I, Schmoll HJ. CUP. In: Schmoll HJ, ed. Kompendium Internistische Onkologie Band 2. Berlin/Heidelberg/New York: Springer-Verlag, 1999:2137-2182.
6. van de Wouw AJ, Jansen RLH, Griffioen AW, Hillen HFP. Clinical and immu-nohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT. Anticancer Res 2004; 24:297-302.
7. Penel N. Prise en charge diagnostique des metastases inaugurales. Presse Med 2003; 32:990-996.
8. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004; 100:1776-1785.
9. Lesimple T, Voigt JJ, Bataillard A, et al. Recommandations pour la pratique clinique: Standards, Options et Recommandations 2002 pour le diagnostic des carcinomes de site primitif inconnu. Bull Cancer 2003; 90:1071-1096.
10. Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer 1999; 35:1076-1082.
11. Anonymous. NCCN practice guidelines for occult primary tumours. National Comprehensive Cancer Network. Oncology 1998; 12:226-309.
12. Penel N. Pronostic et possibilites therapeutiques des metastases inaugurales. Presse Med 2003; 32:997-1004.
13. Bugat R, Bataillard A, Lesimple T, et al. Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site. Br J Cancer 2003; 89(suppl 1):S59-S66.
14. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Engl J Med 1993; 329:257-263.
15. Zuur CL, van Velthuysen MLF, Schornagel JH, Hilgers FJM, Balm AJM. Diagnosis and treatment of isolated neck metastases of adenocarcinomas. Eur J Surg Oncol 2002; 28:147-152.
16. Riquet M, Badoual C, le Pimpec Barthes F, Dujon A, Danel C. Metastatic thoracic lymph node carcinoma with unknown primary site. Ann Thorac Surg 2003; 75:244-249.
17. Faure E, Riquet M, Lombe-Weta PM, Hübsch JP, Carnot F. Adenopathies tumorales du mediastin sans cancer primitif. Rev Mal Respir 2000; 17:1095-1099.
18. Mousseau M, Schaerer R, Lutz JM, Menegoz F, Faure H, Swiercz P. Metastases hepatiques de site primitif inconnu. Bull Cancer 1991; 78:725-736.
19. Hogan BA, Thornton FJ, Brannigan M, et al. Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations. Clin Radiol 2002; 57:1073-1077.
20. Tot T, Samii S. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis. APMIS 2003; 111:1075-1082.
21. Hawksworth J, Geisinger K, Zagoria R, et al. Surgical and ablative treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg 2004; 70:512-517.
22. Schwartz SI. Hepatic resection for noncolorectal nonneuroendocrine metastases. World J Surg 1995; 19:72-75.
23. Berney T, Mentha G, Roth AD, Morel P. Results of surgical resection of liver metastases from non-colorectal primaries. Br J Surg 1998; 85:1423-1427.
24. Briasoulis E, Kalofonos H, Bafaloukos D, et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol 2000; 18:3101-3107.
25. Ayoub JP, Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Unknown primary tumors metastatic to liver. J Clin Oncol 1998; 16:2105-2112.
26. Alcalay M, Azais I, Brigeon B, et al. Strategy for identifying primary malignancies with inaugural bone metastases. Rev Rhum Engl Ed 1995; 62:632-642.
27. Conroy T, Platini C, Troufleau P, et al. Presentation clinique et facteurs pronostiques au diagnostic de metastases osseuses. A propos d'une serie de 578 observations. Bull Cancer 1993; 80(suppl 10):16-22.
28. Rougraff BT. Evaluation of the patient with carcinoma of unknown origin metastatic to bone. Clin Orthop 2003; 415(suppl):S105-S109.
29. Wedin R, Bauer HCF, Skoog L, Soderlund V, Tani E. Cytological diagnosis of skeletal lesions. Fine-needle aspiration biopsy in 110 tumours. J Bone Joint Surg Br 2000; 82:673-678.
30. Enkaoua EA, Doursounian L, Chatellier G, Mabesoone F, Aimard T, Saillant G. Vertebral metastases: a critical appreciation of the preoperative prognostic Tokuhashi score in a series of 71 cases. Spine 1997; 22:2293-2298.
31. Gambhir SS, Shepherd JE, Shah BD, et al. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 1998; 16:2113-2125.
32. Bonnefoi H, Smith IE. How should cancer presenting as a malignant pleural effusion be managed? Br J Cancer 1996; 74:832-835.
33. Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Eur Respir J 2001; 18:402-419.
34. Ang P, Tan EH, Leong SS, et al. Primary intrathoracic malignant effusion: a descriptive study. Chest 2001; 120:50-54.
35. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322:494-500.
36. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33:583-590.
37. Ruda R, Borgognone M, Benech F, Vasario E, Soffietti R. Brain metastases from unknown primary tumour: a prospective study. J Neurol 2001; 248:394-398.
38. Nguyen LN, Maor MH, Oswald MJ. Brain metastases as the only manifestation of an undetected primary tumor. Cancer 1998; 83:2181-2184.
39. Bartelt S, Lutterbach J. Brain metastases in patients with cancer of unknown primary. J Neurooncol 2003; 64:249-253.
40. Salvati M, Cervoni L, Raco A. Single brain metastases from unknown primary malignancies in CT-era. J Neurooncol 1995; 23:75-80.
41. Khansur T, Routh A, Hickman B. Brain metastases from unknown primary site. J Miss State Med Assoc 1997; 38:238-242.
42. Soffietti R, Ruda R, Mutani R. Management of brain metastases. J Neurol 2002; 249:1357-1369.
43. Mintz AH, Kestle J, Rathbone MP, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996; 78:1470-1476.
44. Glockner JF, White LM, Sundaram M, McDonald DJ. Unsuspected metastases presenting as solitary soft tissue lesions: a fourteen-year review. Skeletal Radiol 2000; 29:270-274.